We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

4 hedge funds and large institutions have $2.43K invested in Artelo Biosciences, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

51% less capital invested

Capital invested by funds: $5K → $2.43K (-$2.57K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$685

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$641
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$1.09K -$641 -7,701 -22%
AGM
2
Alpine Global Management
New York
$1K – – –
UBS Group
3
UBS Group
Switzerland
$329 +$685 +8,223 New
Morgan Stanley
4
Morgan Stanley
New York
$6 – – –

ARTLW Hedge Fund Activity: Q4 2022 in Review

4 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q4 2022, worth a combined $2.43K — down 51% from $5K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $685. The largest seller was Verition Fund Management, cutting an estimated $641.

  • 4 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q4 2022, up from 3 in Q3 2022.
  • Funds reported $2.43K of Artelo Biosciences, Inc. Warrant stock for Q4 2022, down 51% quarter-over-quarter.
  • 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q4 2022 and 0 closed out, a net change of +1 holder.
  • The largest Artelo Biosciences, Inc. Warrant buyer in Q4 2022 was UBS Group, an estimated $685 added.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q4 2022 was Verition Fund Management, an estimated $641 sold.

Based on aggregated 13F filings for Q4 2022.